Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term prostate specific antigen. Found 9 abstracts

Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM. Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials. Int J Radiat Oncol Biol Phys. 2019 Aug;104(5):1057-65.   PMCID: PMC6646073
Uzzo RG. Renal cell carcinoma: Urologists in a new era. Journal of Urology. 2005 Nov;174(5):1723-4.
Vicini FA, Vargas C, Abner A, Kestin L, Horwitz E, Martinez A. Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer. Journal of Urology. 2005 Jan;173(5):1456-62.
Fiveash JB, Hanks G, Roach M, Wang SB, Vigneault E, McLaughlin PW, Sandler HM. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review. International Journal of Radiation Oncology Biology Physics. 2000 May;47(2):335-42.
Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?. Radiation Oncology Investigations. 1999 Jan;7(4):249-59.
Hanlon AL, Moore DF, Hanks GE. Modeling postradiation prostate specific antigen level kinetics - Predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma. Cancer. 1998 Jul;83(1):130-4.
Bonin SR, Hanlon AL, Lee WR, Movsas B, AlSaleem TI, Hanks GE. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer. 1997 Jan;79(1):75-80.
Hanks GE. Response to editorial by Zelefsky et al. [1]. International Journal of Radiation Oncology Biology Physics. 1993 Jan;27(2):483.
Hanks GE, Damico A, Epstein BE, Schultheiss TE. Prostatic-Specific Antigen Doubling Times in Patients with Prostate-Cancer - a Potentially Useful Reflection of Tumor Doubling Time. International Journal of Radiation Oncology Biology Physics. 1993 Sep;27(1):125-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term prostate specific antigen

Last updated on Sunday, August 09, 2020